Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Livzon Mabpharm



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
The average size of a deal this fund participated in
Portfolio companies 1
Rounds per year 0.18
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees 1

Areas of investment

  • Life Science
  • Biotechnology
  • Therapeutics

In 2010 was created Livzon Mabpharm, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in China. The main department of described Corporate Investor is located in the Zhuhai.

For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Therapeutics, Life Science. Among the various public portfolio startups of the fund, we may underline Epirus Biopharmaceuticals Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.

The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2005.

The typical case for the fund is to invest in rounds with 8 participants. Despite the Livzon Mabpharm, startups are often financed by Montreux Equity Partners, 5AM Ventures. The meaningful sponsors for the fund in investment in the same round are TPG Biotech, Mousse Partners, Montreux Equity Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Livzon Mabpharm:
Typical Co-investors
Livzon Mabpharm is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Livzon Mabpharm:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Center of Aging and Brain Health Innovation Canada, Ontario, Toronto
Changjiang Zheshang Unity Holdings -
ConvergInce Holdings England, London, United Kingdom
FleetBoston Financial Group Boston, Massachusetts, United States
GAUSS Japan Japan, Kanagawa Prefecture, Kawasaki
Generation Ventures Canada, Ontario, Toronto
Hard Money Collective -
Hezhong Guquan Touzi -
Kaplan Ventures Florida, Miami, United States
Morrag Investments -
Ningbo Huaqiang Ruizhe Investment Partnership China, Ningbo, Zhejiang
Nobska Point Capital Boston, Massachusetts, United States
Portal Capital Beachwood, Ohio, United States
Ride Ventures Mount Kisco, New York, United States
SLATE CAPITAL GROUP Baltimore, Maryland, United States
Stichting DOEN Amsterdam, Noord-Holland, The Netherlands
TerraLab Ventures Hamada, Japan, Shimane Prefecture
TIE Toronto Canada, Ontario, Toronto

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Epirus Biopharmaceuticals

Life Science
$36M16 Apr 2014 Boston, Massachusetts, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Livzon Mabpharm?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 36M
Rounds per year 0.18
Peak activity year 2014
Lead investments 1
Follow on index 0.50
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Epirus Biopharmaceuticals

Life Science
$36M16 Apr 2014 Boston, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: